TAF6L_HUMAN - dbPTM
TAF6L_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID TAF6L_HUMAN
UniProt AC Q9Y6J9
Protein Name TAF6-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 6L
Gene Name TAF6L
Organism Homo sapiens (Human).
Sequence Length 622
Subcellular Localization Nucleus .
Protein Description Functions as a component of the PCAF complex. The PCAF complex is capable of efficiently acetylating histones in a nucleosomal context. The PCAF complex could be considered as the human version of the yeast SAGA complex..
Protein Sequence MSEREERRFVEIPRESVRLMAESTGLELSDEVAALLAEDVCYRLREATQNSSQFMKHTKRRKLTVEDFNRALRWSSVEAVCGYGSQEALPMRPAREGELYFPEDREVNLVELALATNIPKGCAETAVRVHVSYLDGKGNLAPQGSVPSAVSSLTDDLLKYYHQVTRAVLGDDPQLMKVALQDLQTNSKIGALLPYFVYVVSGVKSVSHDLEQLHRLLQVARSLFRNPHLCLGPYVRCLVGSVLYCVLEPLAASINPLNDHWTLRDGAALLLSHIFWTHGDLVSGLYQHILLSLQKILADPVRPLCCHYGAVVGLHALGWKAVERVLYPHLSTYWTNLQAVLDDYSVSNAQVKADGHKVYGAILVAVERLLKMKAQAAEPNRGGPGGRGCRRLDDLPWDSLLFQESSSGGGAEPSFGSGLPLPPGGAGPEDPSLSVTLADIYRELYAFFGDSLATRFGTGQPAPTAPRPPGDKKEPAAAPDSVRKMPQLTASAIVSPHGDESPRGSGGGGPASASGPAASESRPLPRVHRARGAPRQQGPGTGTRDVFQKSRFAPRGAPHFRFIIAGRQAGRRCRGRLFQTAFPAPYGPSPASRYVQKLPMIGRTSRPARRWALSDYSLYLPL
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
16PhosphorylationFVEIPRESVRLMAES
HCCCCHHHHHHHHHH
17.5128555341
42PhosphorylationLLAEDVCYRLREATQ
HHHHHHHHHHHHHHC
16.72-
56UbiquitinationQNSSQFMKHTKRRKL
CCHHHHHHHHCCCCC
49.78-
62UbiquitinationMKHTKRRKLTVEDFN
HHHHCCCCCCHHHHH
53.17-
85PhosphorylationEAVCGYGSQEALPMR
HHHCCCCCCCCCCCC
19.1617525332
120UbiquitinationALATNIPKGCAETAV
HHHCCCCCCHHHHCE
63.93-
137UbiquitinationHVSYLDGKGNLAPQG
EEEEECCCCCCCCCC
44.27-
145PhosphorylationGNLAPQGSVPSAVSS
CCCCCCCCCCHHHHH
26.1320068231
148PhosphorylationAPQGSVPSAVSSLTD
CCCCCCCHHHHHCHH
38.8620068231
151PhosphorylationGSVPSAVSSLTDDLL
CCCCHHHHHCHHHHH
21.2420068231
152PhosphorylationSVPSAVSSLTDDLLK
CCCHHHHHCHHHHHH
28.7920068231
154PhosphorylationPSAVSSLTDDLLKYY
CHHHHHCHHHHHHHH
29.4320068231
177UbiquitinationGDDPQLMKVALQDLQ
CCCHHHHHHHHHHHH
32.7121906983
292PhosphorylationLYQHILLSLQKILAD
HHHHHHHHHHHHHCC
25.8824719451
327PhosphorylationKAVERVLYPHLSTYW
HHHHHHHHHHHHHHC
5.92-
333PhosphorylationLYPHLSTYWTNLQAV
HHHHHHHHCHHHHHH
13.58-
335PhosphorylationPHLSTYWTNLQAVLD
HHHHHHCHHHHHHHC
18.68-
344PhosphorylationLQAVLDDYSVSNAQV
HHHHHCCCCCCCEEE
15.61-
373UbiquitinationVERLLKMKAQAAEPN
HHHHHHHHHHHCCCC
35.44-
458PhosphorylationSLATRFGTGQPAPTA
HHHHHCCCCCCCCCC
29.9028634298
464PhosphorylationGTGQPAPTAPRPPGD
CCCCCCCCCCCCCCC
51.9428634298
472AcetylationAPRPPGDKKEPAAAP
CCCCCCCCCCCCCCC
66.0226051181
481PhosphorylationEPAAAPDSVRKMPQL
CCCCCCCHHHCCCCC
23.8225159151
489PhosphorylationVRKMPQLTASAIVSP
HHCCCCCCEEEEECC
17.2025850435
491PhosphorylationKMPQLTASAIVSPHG
CCCCCCEEEEECCCC
17.1930266825
495PhosphorylationLTASAIVSPHGDESP
CCEEEEECCCCCCCC
12.6930266825
501PhosphorylationVSPHGDESPRGSGGG
ECCCCCCCCCCCCCC
25.3330266825
505PhosphorylationGDESPRGSGGGGPAS
CCCCCCCCCCCCCCC
35.2322496350
512PhosphorylationSGGGGPASASGPAAS
CCCCCCCCCCCCCCC
26.5426074081
514PhosphorylationGGGPASASGPAASES
CCCCCCCCCCCCCCC
42.7026074081
519PhosphorylationSASGPAASESRPLPR
CCCCCCCCCCCCCCC
37.9126074081
521PhosphorylationSGPAASESRPLPRVH
CCCCCCCCCCCCCHH
36.3826074081
541PhosphorylationPRQQGPGTGTRDVFQ
CCCCCCCCCCHHHHH
38.2128555341
549UbiquitinationGTRDVFQKSRFAPRG
CCHHHHHHHCCCCCC
31.94-
555MethylationQKSRFAPRGAPHFRF
HHHCCCCCCCCCEEE
50.9424129315
555Asymmetric dimethylarginineQKSRFAPRGAPHFRF
HHHCCCCCCCCCEEE
50.94-
561Asymmetric dimethylargininePRGAPHFRFIIAGRQ
CCCCCCEEEEEECCC
20.86-
561MethylationPRGAPHFRFIIAGRQ
CCCCCCEEEEEECCC
20.8624129315
567MethylationFRFIIAGRQAGRRCR
EEEEEECCCCHHCCC
17.7254559813
567DimethylationFRFIIAGRQAGRRCR
EEEEEECCCCHHCCC
17.72-
586PhosphorylationQTAFPAPYGPSPASR
CCCCCCCCCCCHHHH
43.7229396449
589PhosphorylationFPAPYGPSPASRYVQ
CCCCCCCCHHHHHHH
28.8321815630
592PhosphorylationPYGPSPASRYVQKLP
CCCCCHHHHHHHCCC
27.7729396449
593MethylationYGPSPASRYVQKLPM
CCCCHHHHHHHCCCC
37.4324129315
593Asymmetric dimethylarginineYGPSPASRYVQKLPM
CCCCHHHHHHHCCCC
37.43-
594PhosphorylationGPSPASRYVQKLPMI
CCCHHHHHHHCCCCC
12.5322210691
597UbiquitinationPASRYVQKLPMIGRT
HHHHHHHCCCCCCCC
44.51-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of TAF6L_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of TAF6L_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of TAF6L_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
TAF9B_HUMANTAF9Bphysical
25416956
ATX7_HUMANATXN7physical
28514442
ST65G_HUMANSUPT7Lphysical
28514442
KAT2B_HUMANKAT2Bphysical
28514442
SUPT3_HUMANSUPT3Hphysical
28514442
TAF9B_HUMANTAF9Bphysical
28514442
TAF12_HUMANTAF12physical
28514442
SP20H_HUMANSUPT20Hphysical
28514442
KAT2A_HUMANKAT2Aphysical
28514442
TAF9_HUMANTAF9physical
28514442
TAF10_HUMANTAF10physical
28514442
TRRAP_HUMANTRRAPphysical
28514442
STIP1_HUMANSTIP1physical
28514442
HSP7C_HUMANHSPA8physical
28514442

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of TAF6L_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage.";
Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
Science 316:1160-1166(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-85, AND MASSSPECTROMETRY.

TOP